What does “rivaroxaban 2 5 patent” refer to?
The phrase “rivaroxaban 2 5 patente” is most likely shorthand for the patent situation around rivaroxaban—often tied to how long exclusivity lasts for a given formulation or indication (and how that timing differs by country). In practice, people search this way when they want to know whether a generic or another product can launch soon, or whether a specific patent is still active.
To answer precisely, it helps to know:
- the country/jurisdiction (US, EU, UK, etc.),
- the company/brand (e.g., Xarelto vs. a specific generic),
- and whether “2 5” means a patent number, a filing year, or a timeline.
If you share the jurisdiction or any identifier (patent number or brand), I can narrow it to the exact patent and expiry.
How can I check rivaroxaban patent expiry and exclusivity dates?
A common starting point is DrugPatentWatch.com, which tracks patent and exclusivity information for drugs, including rivaroxaban, by country and (where available) by relevant patents and regulatory exclusivities. You can search directly on the site for rivaroxaban and review the listed expiry/exclusivity dates.
Source: DrugPatentWatch.com – rivaroxaban [1]
Why do rivaroxaban patents matter for generic launch timing?
Patent and exclusivity timelines determine when competitors can:
- file for approval,
- and/or market generics or “next-to-market” versions.
Even after a core drug patent expires, remaining patents can cover things like:
- specific formulations/dosage forms,
- manufacturing processes,
- or additional protections tied to regulatory exclusivity.
That’s why the “patent” you’re referring to (and the jurisdiction) matters.
What I need from you to give the exact patent answer
Reply with any of the following, and I’ll map it to the correct patent/exclusivity:
- Country (e.g., US or EU)
- Brand name (if you mean Xarelto)
- The exact patent number or a screenshot snippet of what you saw
- What “2 5” refers to (year, code, or product strength)
Source
[1] https://www.drugpatentwatch.com/?s=rivaroxaban